The approach to treating hematological malignancies is rapidly evolving as we discover the underlying mechanisms of disease and identify new immune pathways within the patient’s body to harness. Immunotherapies have proven successful in treating some cancers, yet there is more to be done to unravel the complexity of blood cancers and develop increasingly personalized, targeted agents.
Download this research highlight to discover how to:
- Identify novel targets
- Better understand therapeutic response including relapse
- Drive targets through development